Baylor Scott and White Research Institute, Charles A. Sammons Cancer Center
3535 Worth Street
Dallas, Texas 75246

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Refractory Multiple Myeloma Clinical Trial
A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Baylor Scott and White Research Institute, Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials